1. Home
  2. TGTX vs SSL Comparison

TGTX vs SSL Comparison

Compare TGTX & SSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TG Therapeutics Inc.

TGTX

TG Therapeutics Inc.

N/A

Current Price

$64.36

Market Cap

8.5B

Sector

Health Care

ML Signal

N/A

Logo Sasol Ltd.

SSL

Sasol Ltd.

N/A

Current Price

$12.15

Market Cap

7.4B

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
TGTX
SSL
Founded
1993
1950
Country
United States
South Africa
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
7.4B
IPO Year
2008
2002

Fundamental Metrics

Financial Performance
Metric
TGTX
SSL
Price
$64.36
$12.15
Analyst Decision
Buy
Analyst Count
8
0
Target Price
★ $69.43
N/A
AVG Volume (30 Days)
★ 1.8M
1.7M
Earning Date
11-09-2026
02-22-2027
Dividend Yield
N/A
N/A
EPS Growth
★ 1746.67
N/A
EPS
★ 0.52
N/A
Revenue
★ $2,785,000.00
N/A
Revenue This Year
$61.95
$5.37
Revenue Next Year
$35.55
N/A
P/E Ratio
$120.60
★ $13.51
Revenue Growth
N/A
★ N/A
52 Week Low
$26.76
$5.97
52 Week High
$68.03
$18.19

Technical Indicators

Market Signals
Indicator
TGTX
SSL
Relative Strength Index (RSI) 60.53 27.27
Support Level $52.12 $12.04
Resistance Level $63.60 $12.46
Average True Range (ATR) 3.52 0.47
MACD 0.14 -0.41
Stochastic Oscillator 64.62 0.00

Price Performance

Historical Comparison
TGTX
SSL

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.

About SSL Sasol Ltd.

Sasol Ltd operates as a vertically integrated chemicals and energy company through its two main businesses: the Southern Africa Energy & Chemicals business and the International Chemical business. It generates maximum revenue from the Southern Africa Energy & Chemicals business, which operates integrated value chains with feedstock sourced from the Mining and Gas operating segments. Geographically, the company generates the majority of its revenue from South Africa.

Share on Social Networks: